The updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma

Johanna Mangana1, Berna C Özdemir2, Daniela Mihic-Probst3

  • 1Skin Cancer Centre, Department of Dermatology, University of Zurich, University Hospital of Zurich, Zurich, Switzerland.

Swiss Medical Weekly
|August 14, 2025
PubMed

Insights

Melanoma treatment has advanced significantly due to new molecular discoveries, leading to improved outcomes. Updated guidelines are now essential to incorporate recent surgical, radiotherapeutic, and systemic therapies, including adjuvant and neoadjuvant approaches.

Area of Science:

  • Oncology
  • Dermatology
  • Medical Guidelines

Background:

  • Global incidence of melanoma is rising.
  • Mortality rates in Caucasian populations have decreased by 18% due to effective systemic treatments.
  • Melanoma management has transformed over the last decade owing to molecular insights.

Purpose of the Study:

  • To update the 2016 Swiss guidelines for melanoma management.
  • To incorporate recent advancements in surgical, radiotherapeutic, and systemic treatments.
  • To provide evidence-based recommendations for adjuvant and neoadjuvant therapies.

Main Methods:

  • Review of recent clinical data on melanoma treatment.
  • Analysis of surgical, radiotherapeutic, and systemic therapy outcomes.
  • Synthesis of evidence for guideline modification.

Main Results:

  • Significant advancements in systemic treatments have improved melanoma survival.
  • Adjuvant and neoadjuvant therapies represent key developments in current management.
  • The 2016 guidelines require substantial updates to reflect current practices.

Conclusions:

  • Updated guidelines are crucial for effective melanoma management.
  • Recommendations must integrate novel treatment modalities.
  • Modified guidelines will support optimal patient care and follow-up.

Related Concept Videos